Evidence map›Paper›PMID 20952539›Full record

ArticleGenes & development2010

CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1.

Bartlomiej Bartkowiak, Pengda Liu, Hemali P Phatnani, Nicholas J Fuda, Jeffrey J Cooper, David H Price, Karen Adelman, John T Lis, Arno L Greenleaf

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 254 papers.

0numbers the graph read from it
0cells of the map it votes in
254citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

254 citing papers in PubMed, 397 citations in OpenAlex.

  1. Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Targeting CDKs in the RNAPII transcription cycle.Nature reviews. Drug discovery · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Dual Modes of Gene Regulation by CDK12.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

194 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Bartlomiej BartkowiakDepartment of Biochemistry, Duke Center for RNA Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Pengda Liu
Hemali P Phatnani
Nicholas J Fuda
Jeffrey J Cooper
David H Price
Karen Adelman
John T Lis
Arno L Greenleaf
Duke Medical Center · USCornell University · USUniversity of Iowa · USDuke University Hospital · USNational Institute of Environmental Health Sciences · US

Funding

Investigating Transcriptional Responses to the EnvironmentZIAES101987 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ADELMAN, KAREN L · 2009 to 2016
$15.9M
COORDINATE GENE REGULATION IN ANIMAL CELLSR01GM025232 · NIGMS · CORNELL UNIVERSITY ITHACA · PI LIS, JOHN T · 1985 to 2020
$8.4M
FACTORS INVOLVED IN TRANSCRIPTION BY RNA POLYMERSASE IIR01GM035500 · NIGMS · UNIVERSITY OF IOWA · PI PRICE, DAVID H · 1985 to 2017
$6.5M
TRANSCRIPTASE KINASES FROM YEAST AND DROSOPHILAR01GM040505 · NIGMS · DUKE UNIVERSITY · PI GREENLEAF, ARNO L. · 1988 to 2014
$5.1M
Investigating Transcriptional Responses to the EnvironmentZ01ES101987 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ADELMAN, KAREN L · 2006 to 2008
$2.8M
COORDINATE GENE REGULATION IN ANIMAL CELLSR37GM025232 · NIGMS · CORNELL UNIVERSITY ITHACA · PI LIS, JOHN THOMAS · 1995 to 2004
$2.5M
Analysis of interactions of HIV Tat and TAR with HEXIM1, 7SK, and P-TEFbR33AI074392 · NIAID · UNIVERSITY OF IOWA · PI PRICE, DAVID H · 2009 to 2011
$1.1M
Intramural NIH HHS Z01 ES101987NIAID NIH HHS R33 AI074392NIGMS NIH HHS GM025232NIGMS NIH HHS GM035500NIGMS NIH HHS GM040505NIGMS NIH HHS R01 GM025232NIGMS NIH HHS R01 GM035500NIGMS NIH HHS R01 GM040505NIGMS NIH HHS R37 GM025232
6 · The paper itself

Abstract

Drosophila contains one (dCDK12) and humans contain two (hCDK12 and hCDK13) proteins that are the closest evolutionary relatives of yeast Ctk1, the catalytic subunit of the major elongation-phase C-terminal repeat domain (CTD) kinase in Saccharomyces cerevisiae, CTDK-I. However, until now, neither CDK12 nor CDK13 has been demonstrated to be a bona fide CTD kinase. Using Drosophila, we demonstrate that dCDK12 (CG7597) is a transcription-associated CTD kinase, the ortholog of yCtk1. Fluorescence microscopy reveals that the distribution of dCDK12 on formaldehyde-fixed polytene chromosomes is virtually identical to that of hyperphosphorylated RNA polymerase II (RNAPII), but is distinct from that of P-TEFb (dCDK9 + dCyclin T). Chromatin immunoprecipitation (ChIP) experiments confirm that dCDK12 is present on the transcribed regions of active Drosophila genes. Compared with P-TEFb, dCDK12 amounts are lower at the 5' end and higher in the middle and at the 3' end of genes (both normalized to RNAPII). Appropriately, Drosophila dCDK12 purified from nuclear extracts manifests CTD kinase activity in vitro. Intriguingly, we find that cyclin K is associated with purified dCDK12, implicating it as the cyclin subunit of this CTD kinase. Most importantly, we demonstrate that RNAi knockdown of dCDK12 in S2 cells alters the phosphorylation state of the CTD, reducing its Ser2 phosphorylation levels. Similarly, in human HeLa cells, we show that hCDK13 purified from nuclear extracts displays CTD kinase activity in vitro, as anticipated. Also, we find that chimeric (yeast/human) versions of Ctk1 containing the kinase homology domains of hCDK12/13 (or hCDK9) are functional in yeast cells (and also in vitro); using this system, we show that a bur1(ts) mutant is rescued more efficiently by a hCDK9 chimera than by a hCDK13 chimera, suggesting the following orthology relationships: Bur1 ↔ CDK9 and Ctk1 ↔ CDK12/13. Finally, we show that siRNA knockdown of hCDK12 in HeLa cells results in alterations in the CTD phosphorylation state. Our findings demonstrate that metazoan CDK12 and CDK13 are CTD kinases, and that CDK12 is orthologous to yeast Ctk1.

Indexed as

AnimalsBlotting, WesternCDC2 Protein KinaseCell LineChromosome MappingCyclin-Dependent Kinase 9Cyclin-Dependent KinasesCyclin TDrosophila melanogasterDrosophila ProteinsGenetic Complementation TestHeLa CellsHumansMicroscopy, FluorescenceMutationPhosphorylationcarboxy-terminal domain kinaseCDC2 Protein KinaseCDK13 protein, humanCTDK-I protein complex, S cerevisiaeCyclin-Dependent Kinase 9Cyclin-Dependent KinasesCyclin TDrosophila ProteinsProtein KinasesRecombinant Fusion ProteinsRNA Polymerase IISaccharomyces cerevisiae Proteins

Identifiers

PMID20952539
PMCPMC2956209
OpenAlexW2117800899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.